Asymptomatic COVID-19 Infection Among Healthcare Workers
NCT04354792 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2020-06-17
Summary
To assess the seroprevalence of SARS-CoV-2 IgG in Health care workers in three University Hospitals
Conditions
- Immunologic Activity Alteration
Interventions
- DIAGNOSTIC_TEST
-
Serum SARs COV 2 IGg screening in health care workers
Blood samples will be collected from the enrolled HCWs. Sample collection, processing, and laboratory testing will follow guidance from the World Health Organization
Sponsors & Collaborators
-
Kasr El Aini Hospital
lead OTHER
Principal Investigators
-
Ahmed M Mukhtar, M.D · Cairo University
Eligibility
- Min Age
- 25 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-05-01
- Primary Completion
- 2020-06-10
- Completion
- 2020-06-10
Countries
- Egypt
Study Locations
More Related Trials
-
Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection
NCT04342650 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Biomarkers in the Long-term Impact of Coronavirus Infection in the Cardiorespiratory System
NCT04353245 ·Status: UNKNOWN
-
Asymptomatic COVID-19 Trial
NCT04374552 ·Status: WITHDRAWN ·Phase: PHASE2
-
Assessment of Efficacy and Safety of HCQ and Antibiotics Administrated to Patients COVID19(+)
NCT04351919 ·Status: WITHDRAWN ·Phase: PHASE4
-
Add on to Azythromycine, Phytomedicine and/or Antimalarial Drug vs Hydroxychloroquine in Uncomplicated COVID-19 Patients
NCT04502342 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacay of Chloroquine or Hydroxychloroquine in COVID-19 Treatment
NCT04353336 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy of Mefloquine as Prophylaxis Against COVID-19: A Placebo-control, Randomized Clinical Trial
NCT04847661 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Phytomedicines Versus Hydroxychloroquine as an Add on Therapy to Azythromycin in Asymptomatic Covid-19 Patients
NCT04501965 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluating the Efficacy of Artesunate in Adults With Mild Symptoms of COVID-19
NCT04387240 ·Status: WITHDRAWN ·Phase: PHASE2
-
Prevention With Chloroquine in Health Personnel Exposed to Infection With Coronavirus Disease 2019 (COVID-19) (TS-COVID)
NCT04627467 ·Status: COMPLETED ·Phase: PHASE2
-
PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds
NCT04351191 ·Status: TERMINATED ·Phase: PHASE4
-
Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2
NCT04323527 ·Status: COMPLETED ·Phase: PHASE2
-
Covid-19 Data Analyses in Brazil
NCT06652451 ·Status: COMPLETED
-
Safety and Protective Efficacy of IV Immunization With Cryopreserved PfSPZ Under A/P Chemoprophylaxis
NCT02858817 ·Status: COMPLETED ·Phase: PHASE1
-
Merozoite Surface Protein 1 Antibody Response in Asymptomatic Human Malaria Infection
NCT00761020 ·Status: COMPLETED ·Phase: NA
-
Dynamics of Subclinical Malaria: Preliminary Study
NCT03483571 ·Status: COMPLETED
-
Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds
NCT04346667 ·Status: TERMINATED ·Phase: PHASE4
-
HOPE: A Trial of Hydroxichloroquine Plus Azithromycin in High Risk COVID-19
NCT04575558 ·Status: WITHDRAWN ·Phase: PHASE2
-
Effectiveness of OZ439 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Volunteers
NCT02453581 ·Status: COMPLETED ·Phase: PHASE1
-
Parasitic Infection in Anemic Pregnant Women
NCT04391998 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Evaluate the Safety and Efficacy of OT-101+Artemisinin in Hospitalized COVID-19 Subjects
NCT04801017 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluation of Prognostic Modification in COVID-19 Patients in Early Intervention Treatment
NCT04673214 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19
NCT04359537 ·Status: UNKNOWN ·Phase: PHASE2
-
Effectiveness of Hydroxychloroquine in Covid-19 Patients
NCT04328272 ·Status: UNKNOWN ·Phase: PHASE3
-
An Observational Study to Assess the Protocol for the COVID-19 Treatment in Burkina Faso
NCT04445441 ·Status: COMPLETED